In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB).

Source:http://linkedlifedata.com/resource/pubmed/id/21546571

Cancer Res. 2011 Jul 1 71 13 4617-27

Download in:

View as

General Info

PMID
21546571